← Back to Patent Explorer
US4994558A Expired / Lapsed US ⏱️ 0.0 years remaining

Immunoglobulin conjugates

Assignee: Eli Lilly and Co
•
Filing: 1989-01-09
•
Granted: 1991-02-19
•
Expires: 2009-01-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Immunoglobulin conjugates formed by reacting a difluoronucleoside with an immunoglobulin via an alkane dioic acid linking group.

Inventors

  • 👤 Henry K. Armour
  • 👤 G. Davon Kennedy
  • 👤 Gary A. Koppel
  • 👤 William L. Scott

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 10:25
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6801; A61K47/6803; A61K47/6807

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 142 words
A conjugate of the formula (Q) n --Im where Im is an immunoglobulin or immunoglobulin fragment, n is about 1-10, and Q is an acylated difluoronucleoside of the formula ##STR6## wherein the --R--NH-- moiety is ##STR7## R 1 is hydrogen, C 1 -C 4 alkyl, --COR 3 , or --COXCO--; R 2 is hydrogen or --COXCO--; R 4 is hydrogen, C 1 -C 4 alkyl, amino, bromo, fluoro, chloro, or iodo; R 3 is hydrogen or C 1 -C 4 alkyl; X is a bond, C 1 -C 10 straight chain alkylene, C 2 -C 10 branched alkylene, C 2 -C 10 alkenylene, C 3 -C 10 alkynylene, C 3 -C 6 cycloalkylene, phenylene, or hydroxysubstituted C 1 -C 10 alkylene, and A is N or C-R 4; provided that one and only one of R 1 and R 2 is --COXCO--.
Claim 2
Dependent Claim 142 words
A conjugate of the formula (Q) n --Im where Im is an immunoglobulin or immunoglobulin fragment, n is about 1-10, and Q is an acylated difluoronucleoside of the formula ##STR6## wherein the --R--NH-- moiety is ##STR7## R 1 is hydrogen, C 1 -C 4 alkyl, --COR 3 , or --COXCO--; R 2 is hydrogen or --COXCO--; R 4 is hydrogen, C 1 -C 4 alkyl, amino, bromo, fluoro, chloro, or iodo; R 3 is hydrogen or C 1 -C 4 alkyl; X is a bond, C 1 -C 10 straight chain alkylene, C 2 -C 10 branched alkylene, C 2 -C 10 alkenylene, C 3 -C 10 alkynylene, C 3 -C 6 cycloalkylene, phenylene, or hydroxysubstituted C 1 -C 10 alkylene, and A is N or C-R 4; provided that one and only one of R 1 and R 2 is --COXCO--.
Claim 3
Dependent Claim 10 words
A conjugate of claim 1 wherein R 2 is hydrogen.
Claim 4
Dependent Claim 11 words
A conjugate of claim 2 wherein --R--NH-- is a 4-amino-2-oxo-1-pyrimidinyl radical.
Claim 5
Dependent Claim 13 words
A conjugate of claim 3 wherein X is C 2 -C 4 alkylene.
Claim 6
Dependent Claim 9 words
A conjugate of claim 4 wherein Q is 5'-O-(1,4-dioxobutyl)-2'-deoxy-2',2'-difluorocytidinyl.
Claim 7
Dependent Claim 16 words
A conjugate according to claim 1 in which IM is an immunoglobulin which specifically binds antigen.
Claim 8
Dependent Claim 14 words
A conjugate according to claim 6 in which the immunoglobulin is a monoclonal antibody.
Claim 9
Dependent Claim 14 words
A conjugate according to claim 7 in which the MoAb recognizes human cancer cells.
Claim 10
Dependent Claim 36 words
A conjugate according to claim 8 in which the MoAb recognizes human cancer cells selected from the group consisting of adenocarcinoma, squamous cell carcinoma, transitional cell carcinoma, melanoma, neuroblastoma, small cell carcinoma, leukemia, lymphoma, and sarcoma.
Claim 11
Dependent Claim 10 words
A conjugate according to claim 9 wherein Q is 5'-O-(1,4-dioxobutyl)-2'-deoxy-2',2'-difluorocytidinyl.
Claim 12
Dependent Claim 17 words
A conjugate according to claim 9 wherein the MoAb is adapted for recognition of human adenocarcinoma cells.
Claim 13
Dependent Claim 17 words
A conjugate according to claim 10 wherein the MoAb is adapted for recognition of human adenocarcinoma cells.

References Cited (Backward Citations)

GB1446536A Cited
GB1523980A Cited
US4340728A Cited
EP0088695A2 Cited
US4526988A Cited
US4692434A Cited
GB2137210A Cited
US4845200A Cited
US4650675A Cited
US4816569A Cited
EP0184365A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-02-18 1994-08-20 1995-02-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-02-18 1998-08-20 1999-02-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-02-18 2002-08-20 2003-02-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag